HER3/Akt/mTOR pathway is a key therapeutic target for the reduction of triple-negative breast cancer metastasis via the inhibition of CXCR4 expression

por Takeda, Tomoya, Tsubaki, Masanobu, Genno, Shuji, Tokunaga, Kenta, Tanaka, Remi, Nishida, Shozo
Publicado 2023

Hypoxia-inducible factor 1α inhibitor induces cell death via suppression of BCR-ABL1 and Met expression in BCR-ABL1 tyrosine kinase inhibitor sensitive and resistant chronic myeloi...

por Tsubaki, Masanobu, Takeda, Tomoya, Matsuda, Takuya, Kimura, Akihiro, Tanaka, Remi, Nagayoshi, Sakiko, Hoshida, Tadafumi, Tanabe, Kazufumi, Nishida, Shozo
Publicado 2023